Presentation TCT 2012 TCT-51. Comparison of Clopidogrel and Prasugrel in Patients with Unprotected Left main Disease Treated with Everolimus-eluting Stents: Insight from the Florence Left Main-PCI... Presenter: Renato Valenti October 23, 2012
Presentation TCT 2012 TCT-49. A Comparison of 5 mg Prasugrel with 75 mg Clopidogrel in Very Elderly Coronary Artery Disease Patients: Pharmacodynamics and Rates of High on-Treatment Reactivity Presenter: Joseph Jakubowski October 23, 2012
Presentation TCT 2012 TCT-55. Major Adverse Cardiac Events Associated with Discontinuation of Clopidogrel Treatment Within the First Year After Coronary Stent Implantation in Western Denmark Presenter: Michael Maeng October 23, 2012
Presentation TCT 2012 PARADOX: A Prospective, Randomized Trial of Clopidogrel and Prasugrel in Smokers and Non-Smokers Presenter: Paul Gurbel October 22, 2012
Presentation TCT 2012 A Prospective, Randomized Trial of Tailored Clopidogrel Therapy vs. Prasugrel in Patients with High On-Treatment Platelet Reactivity Presenter: Laurent Bonello October 22, 2012
Presentation Bivalirudin vs. Heparin Plus a GPI in Pts with NSTEMI Undergoing PCI After Clopidogrel Pretreatment Presenter: G. Ndrepepa October 18, 2012
Presentation Factors Contributing to Lower Mortality with Ticagrelor Compared with Clopidogrel in Patients Undergoing CABG Surgery Presenter: Christoph Varenhorst September 26, 2012
Presentation Impact of Clopidogrel Loading Dose in Patients with CKD Undergoing Primary PCI for STEMI Presenter: 56196|JY Kim September 14, 2012
Presentation Association of Clopidogrel Treatment with Risk of Mortality and Cardiovascular Events Following MI in Patients With and Without Diabetes Presenter: Charlotte Andersson September 06, 2012
Presentation ESC 2012 Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial Presenter: Matthew Roe August 28, 2012
Presentation Initial and Chronic Response to Clopidogrel After Stenting for ACS and Influence on Clinical Outcomes Presenter: Thomas Cuisset August 17, 2012
Presentation Prior Smoking Status, Clinical Outcomes, and the Comparison of Ticagrelor with Clopidogrel in ACS Presenter: Jan H. Cornel August 02, 2012
Presentation Pantoprazole Significantly Interferes with Antiplatelet Effect of Clopidogrel Presenter: Maria Serena Parri July 31, 2012
Presentation Clopidogrel Discontinuation After Myocardial Infarction and Risk of Thrombosis Presenter: Mette Charlot July 19, 2012
Presentation Cilostazol Added to Aspirin and Clopidogrel Reduces Revascularization Without Increases in Major Adverse Events in Patients With DES Presenter: Ryota Sakurai July 12, 2012
Presentation Ticagrelor vs. Prasugrel in ACS Patients with High On-Clopidogrel Platelet Reactivity Following PCI Presenter: Dimitrios Alexopoulos July 09, 2012
Presentation Recovery of Platelet Function After Discontinuation of Prasugrel or Clopidogrel in Stable CAD Patients Presenter: Matthew J. Price June 13, 2012
Presentation Prolonged Clopidogrel Use After BMS and DES Placement: The VA Drug-Eluting Stent Study Presenter: David P. Faxon June 08, 2012
Presentation Prognostic Value of High On-Clopidogrel Platelet Reactivity in Bivalirudin- vs. Abciximab-Treated NSTEMI Patients Presenter: Dirk Sibbing June 06, 2012
Presentation Ticagrelor vs. Clopidogrel in Patients with ACS and a History of Stroke or TIA Presenter: Stefan K. James May 31, 2012